SCHEMBL19944109

SCHEMBL19944109

CC(=O)OC1C(N)C(OC2C(N)CC(N)C3OC4(CCCCC4)OC23)OC2COC3(CCCCC3)OC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19619212 0.85 LRAT (0.30) —
SCHEMBL19944063 0.85 — —
SCHEMBL19619250 0.85 LRAT (0.36) —
SCHEMBL19944104 0.81 — —
SCHEMBL19944540 0.77 POLB (0.46) —
SCHEMBL19619219 0.74 — —
SCHEMBL19944108 0.72 — —
SCHEMBL21549585 0.72 CA2 (0.36) —
SCHEMBL13985297 0.71 CA2 (0.39) —
SCHEMBL19479799 0.69 POLB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180064743-A1 NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2018-03-08 — — US disclosed
Send feedback